北方药学
北方藥學
북방약학
JOURNAL OF NORTH PHARMACY
2014年
8期
50-50,79
,共2页
宋丽%王玲%史春雷%李颖
宋麗%王玲%史春雷%李穎
송려%왕령%사춘뢰%리영
比阿培南%发热%恶性血液病%粒细胞缺乏
比阿培南%髮熱%噁性血液病%粒細胞缺乏
비아배남%발열%악성혈액병%립세포결핍
Biapenem%Fever%Malignant hematonosis%Neutropenic
目的：观察比阿培南在化疗后发热的粒缺恶性血液病病人中的临床疗效。方法：回顾性分析2012年10月～2013年10月在我院住院的58例恶性血液病化疗后粒缺伴发热患者应用比阿培南治疗的临床资料。结果：用药有效率为70.7%，G-阴性菌细菌清除率为50%，不良反应率为8.6%。结论：比阿培南用于治疗恶性血液病病人化疗后粒缺伴发热安全有效。
目的：觀察比阿培南在化療後髮熱的粒缺噁性血液病病人中的臨床療效。方法：迴顧性分析2012年10月～2013年10月在我院住院的58例噁性血液病化療後粒缺伴髮熱患者應用比阿培南治療的臨床資料。結果：用藥有效率為70.7%，G-陰性菌細菌清除率為50%，不良反應率為8.6%。結論：比阿培南用于治療噁性血液病病人化療後粒缺伴髮熱安全有效。
목적：관찰비아배남재화료후발열적립결악성혈액병병인중적림상료효。방법：회고성분석2012년10월～2013년10월재아원주원적58례악성혈액병화료후립결반발열환자응용비아배남치료적림상자료。결과：용약유효솔위70.7%，G-음성균세균청제솔위50%，불량반응솔위8.6%。결론：비아배남용우치료악성혈액병병인화료후립결반발열안전유효。
Obje ctive:To evaluate the clinical efficacy of Biapenem for treating febrile neutropenia patients with malignant hematonosis after chemotherapy.Methods: Retrospective analysis the clinical data of a total of 58 febrile neutropenia patients in our hospital which were treated with Biapenem from October 2012 to October 2013. Results: The total clinical efficacy rate was 70.7%, the rate of Gram-negative bacteria eradication was 50%, and the adverse reaction rate was 8.6%. Conclusion: Biapenem in the treatment of febrile neutropenic patients with malignant hematonosis after chemotherapy is safe and effective.
